Fundraising Fox

Biotech Investors & VC Firms in Europe

204 firms in this list, with a median first check of $540K. 19 of them lead rounds. Generated from verified public data and updated continuously.

J2 Ventures
BostonPre-Seed–Series A
5 people
Level One Fund
MiamiSeed–Late Stage
5 people
Newton Biocapital
BrusselsSeed–Series A
5 people
Novalis LifeSciences
HamptonSeed–Late Stage
5 people
Propel Bio Partners
Los AngelesSeed–Series A
5 people
Qiming Venture Partners USA
BellevueSeed–Series A
5 people
Taiho Ventures, LLC
Menlo ParkSeed–Series B
5 people
UCB Ventures
BrusselsSeed–Series A
5 people
Vesalius Biocapital III Partners SàRL
StrassenSeries C–Late Stage$10.8M
5 people
Amino Collective
BerlinPre-Seed–Series A$216K – $1.6M
2 people
DBH Investment Zrt.
BudapestSeed–Series B$216K – $1.6M
2 people
DRI Healthcare
Toronto$7.3M – $36.5M
2 people
New Business Venture Fund
ReykjavíkSeed–Series B$216K – $4.3M
2 people
AbbVie
CambridgeSeed–Late Stage$300K – $3M
1 person
Alliance Jura-Hongrie Venture Capital Fund Management
BudapestSeries A–Series B$324K – $2.8M
1 person
Alpha Ventures
AthensSeries A–Series B$1.6M – $10.8M
1 person
Be8 Ventures
BerlinSeed–Series A$2.2M – $10.8M
1 person
Bridge to Growth
BerlinSeries A–Late Stage$1.1M – $5.4M
1 person
Cencora Ventures
San FranciscoSeed–Series B$1M – $10M
1 person
Dow Venture Capital
MidlandSeed–Series A$250K – $5M
1 person
EMBL Ventures
HeidelbergSeed–Late Stage$108K – $5.4M
1 person
Northern Greece Investment Fund (NGIF)
ThessalonikiGrowth$1.6M – $3.2M
1 person
Tet Ventures
BerlinSeed–Series A$54K – $270K
1 person
BSV Ventures
VilniusSeed–Series A
4 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.